He discusses dosing, site rotation, cumulative exposure, retinal screening, and strategies for responsible, individualized treatment.(Question Link) PCAC Meeting Vote Summary BREAKING NEWS JULY 24, 2026 The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDAs 503A Bulks List.Recommended FOR inclusion: (Yes-No) BPC-157 (86) KPV (86) TB-500 (86) MOTS-c (75) Epitalon (74) Semax (85)Recommended AGAINST inclusion: (Yes-No) DSIP (67) What happens [] READ NEWS Cellular Medicine Mondays Jul 20, 2026 Ep
The Specialist Pharmacy Service (SPS) advises that if a patient is already taking a DPP-4 inhibitor and requires treatment intensification, switching to a GLP-1 receptor agonist (rather than adding it) is the preferred approach
Preliminary experiments have demonstrated the anticipatory nature of AgRP/NPY neurons, whose activity rapidly declines prior to feeding
Before and after each medication thoracic fluid index and plasma renin, aldosterone and ANP were also assessed
Each 1000 mg dose, administered weekly or as needed, is designed to signicantly boost your bodys ability to convert fat into energy, enhancing physical performance and aiding in weight management